HRAS-driven cancer cells are vulnerable to TRPML1 inhibition.


Journal

EMBO reports
ISSN: 1469-3178
Titre abrégé: EMBO Rep
Pays: England
ID NLM: 100963049

Informations de publication

Date de publication:
04 2019
Historique:
received: 03 07 2018
revised: 28 01 2019
accepted: 01 02 2019
pubmed: 23 2 2019
medline: 1 5 2020
entrez: 22 2 2019
Statut: ppublish

Résumé

By serving as intermediaries between cellular metabolism and the bioenergetic demands of proliferation, endolysosomes allow cancer cells to thrive under normally detrimental conditions. Here, we show that an endolysosomal TRP channel, TRPML1, is necessary for the proliferation of cancer cells that bear activating mutations in

Identifiants

pubmed: 30787043
pii: embr.201846685
doi: 10.15252/embr.201846685
pmc: PMC6446245
pii:
doi:

Substances chimiques

MCOLN1 protein, human 0
Transient Receptor Potential Channels 0
Extracellular Signal-Regulated MAP Kinases EC 2.7.11.24
HRAS protein, human EC 3.6.5.2
Proto-Oncogene Proteins p21(ras) EC 3.6.5.2
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCI NIH HHS
ID : P30 CA125123
Pays : United States
Organisme : NCI NIH HHS
ID : R00 CA188593
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS081301
Pays : United States
Organisme : NINDS NIH HHS
ID : R21 NS094860
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2019 The Authors.

Références

Enzymes. 2013;33 Pt A:1-14
pubmed: 25033798
Oncotarget. 2012 Jul;3(7):686-99
pubmed: 22824624
J Biol Chem. 2012 Mar 9;287(11):8082-91
pubmed: 22262857
Nucleic Acids Res. 2015 Jul 1;43(W1):W566-70
pubmed: 25969447
Curr Biol. 2012 Sep 11;22(17):1616-21
pubmed: 22863314
Cell. 2008 Nov 28;135(5):838-51
pubmed: 19041749
EMBO Rep. 2008 Feb;9(2):164-70
pubmed: 18188180
Mol Cell Biol. 2018 Jan 16;38(3):
pubmed: 29158292
Cell Calcium. 2016 Nov;60(5):356-362
pubmed: 27593159
Neuron. 1999 Mar;22(3):451-61
pubmed: 10197526
Cell. 1984 Jul;37(3):1027-33
pubmed: 6430564
Nature. 2016 Jan 21;529(7586):408-12
pubmed: 26760201
Nature. 2015 Jan 29;517(7536):576-82
pubmed: 25631445
Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11411-6
pubmed: 21709267
Biochem J. 2009 Nov 11;424(2):163-7
pubmed: 19811449
J Biol Chem. 2014 Feb 14;289(7):4262-72
pubmed: 24375408
Science. 2009 Jul 24;325(5939):473-7
pubmed: 19556463
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15500-5
pubmed: 16223883
J Biol Chem. 2004 Oct 22;279(43):44311-9
pubmed: 15317812
Dev Biol. 2001 Oct 1;238(1):47-63
pubmed: 11783993
Mol Genet Metab. 2006 Dec;89(4):339-48
pubmed: 16914343
Biophys J. 2016 Apr 26;110(8):1800-1810
pubmed: 27119640
Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):5886-91
pubmed: 15071184
Autophagy. 2014 Oct 1;10(10):1814-26
pubmed: 25136801
Biochim Biophys Acta. 1973 Jan 2;291(1):61-70
pubmed: 4265275
Biochem J. 2005 Jul 1;389(Pt 1):1-11
pubmed: 15954863
Nature. 2017 Jun 1;546(7656):168-172
pubmed: 28538732
Oncotarget. 2016 Jul 12;7(28):43654-43668
pubmed: 27248469
Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14192-7
pubmed: 15381778
Hum Pathol. 2014 Sep;45(9):1957-65
pubmed: 25097040
Genetics. 2003 Jan;163(1):203-15
pubmed: 12586708
Nat Commun. 2012 Mar 13;3:731
pubmed: 22415822
J Vis Exp. 2015 Oct 09;(104):
pubmed: 26484588
Cell. 2017 Jan 12;168(1-2):239-251.e16
pubmed: 28041850
Hum Mol Genet. 2011 Oct 1;20(19):3852-66
pubmed: 21752829
Nat Protoc. 2012 May 03;7(6):1042-51
pubmed: 22555243
EMBO J. 2011 Jul 29;30(16):3242-58
pubmed: 21804531
FASEB J. 2018 Feb;32(2):782-794
pubmed: 29030399
J Biol Chem. 2014 Apr 4;289(14):10211-22
pubmed: 24558044
Sensors (Basel). 2017 Mar 03;17(3):
pubmed: 28273804
J Clin Endocrinol Metab. 2013 Jun;98(6):2502-12
pubmed: 23559083
Sci Rep. 2016 Nov 09;6:36539
pubmed: 27827420
Mol Cell Biol. 2015 Jun 1;35(11):1898-914
pubmed: 25776558
Pharmacol Ther. 2018 Jul;187:45-60
pubmed: 29454854
Nat Cell Biol. 1999 Jun;1(2):98-105
pubmed: 10559881
J Cell Biol. 2003 Jan 20;160(2):165-70
pubmed: 12527752
Proc Biol Sci. 2004 Jun 22;271(1545):1225-34
pubmed: 15306346
Mol Cell Biol. 2015 Nov 16;36(2):363-74
pubmed: 26572827
Nat Cell Biol. 2015 Mar;17(3):288-99
pubmed: 25720963
Sci Signal. 2014 Jan 21;7(309):ra9
pubmed: 24448649
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Genes Dev. 2006 Dec 15;20(24):3426-39
pubmed: 17182868
J Vis Exp. 2013 Jul 17;(77):e50522
pubmed: 23892612
Mol Cell Biol. 2004 Dec;24(23):10437-47
pubmed: 15542851
Oncotarget. 2011 Dec;2(12):1302-6
pubmed: 22185891
J Biol Chem. 1998 Feb 27;273(9):5300-6
pubmed: 9478988
Head Neck. 2014 Nov;36(11):1547-54
pubmed: 24123531
Dev Cell. 2013 Sep 16;26(5):511-24
pubmed: 23993788
Nature. 2015 Aug 20;524(7565):361-5
pubmed: 26168401
Nature. 2013 May 30;497(7451):633-7
pubmed: 23665962
Cell. 2017 Jun 29;170(1):17-33
pubmed: 28666118
Proc Natl Acad Sci U S A. 2015 Feb 3;112(5):E420-9
pubmed: 25605940
Nature. 2013 Apr 4;496(7443):101-5
pubmed: 23535601
Trends Cell Biol. 2004 Mar;14(3):141-7
pubmed: 15003623
Curr Biol. 2012 Jun 5;22(11):945-55
pubmed: 22560614
Biochem J. 1994 May 15;300 ( Pt 1):229-36
pubmed: 8198538
Science. 2011 Jun 17;332(6036):1429-33
pubmed: 21617040
Cancer Lett. 2006 Nov 8;243(1):109-19
pubmed: 16455193
Cell Host Microbe. 2017 Jun 14;21(6):719-730.e6
pubmed: 28579255
J Biol Chem. 2006 Jun 23;281(25):17517-17527
pubmed: 16606612
Nat Commun. 2010 Jul 13;1:38
pubmed: 20802798
Cancer Cell. 2013 Sep 9;24(3):379-93
pubmed: 24029234
Nat Cell Biol. 2001 Apr;3(4):368-75
pubmed: 11283610
Cell. 2012 Apr 27;149(3):656-70
pubmed: 22541435
Science. 2015 Aug 21;349(6250):873-6
pubmed: 26293964
Pharmaceuticals (Basel). 2018 Jan 05;11(1):
pubmed: 29303993

Auteurs

Jewon Jung (J)

Department of Integrative Biology and Pharmacology, McGovern Medical School, the University of Texas Health Sciences Center (UTHealth), Houston, TX, USA.

Kwang-Jin Cho (KJ)

Department of Biochemistry and Molecular Biology, Boonshoft School of Medicine, Wright State University, Dayton, OH, USA.

Ali K Naji (AK)

Department of Diagnostic and Biomedical Sciences, School of Dentistry, The University of Texas Health Science Center, Houston, TX, USA.

Kristen N Clemons (KN)

Department of Integrative Biology and Pharmacology, McGovern Medical School, the University of Texas Health Sciences Center (UTHealth), Houston, TX, USA.
Graduate Program in Biochemistry and Cell Biology, MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.

Ching On Wong (CO)

Department of Integrative Biology and Pharmacology, McGovern Medical School, the University of Texas Health Sciences Center (UTHealth), Houston, TX, USA.

Mariana Villanueva (M)

Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, TX, USA.
Patient Derived Xenografts and Advanced in vivo Models Core Facility, Baylor College of Medicine, Houston, TX, USA.

Steven Gregory (S)

Department of Integrative Biology and Pharmacology, McGovern Medical School, the University of Texas Health Sciences Center (UTHealth), Houston, TX, USA.
Graduate Program in Biochemistry and Cell Biology, MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.

Nicholas E Karagas (NE)

Department of Integrative Biology and Pharmacology, McGovern Medical School, the University of Texas Health Sciences Center (UTHealth), Houston, TX, USA.
Graduate Program in Biochemistry and Cell Biology, MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.

Lingxiao Tan (L)

Department of Integrative Biology and Pharmacology, McGovern Medical School, the University of Texas Health Sciences Center (UTHealth), Houston, TX, USA.
Graduate Program in Biochemistry and Cell Biology, MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.

Hong Liang (H)

Department of Integrative Biology and Pharmacology, McGovern Medical School, the University of Texas Health Sciences Center (UTHealth), Houston, TX, USA.

Morgan A Rousseau (MA)

Department of Integrative Biology and Pharmacology, McGovern Medical School, the University of Texas Health Sciences Center (UTHealth), Houston, TX, USA.

Kelly M Tomasevich (KM)

Department of Integrative Biology and Pharmacology, McGovern Medical School, the University of Texas Health Sciences Center (UTHealth), Houston, TX, USA.

Andrew G Sikora (AG)

Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, TX, USA.
Patient Derived Xenografts and Advanced in vivo Models Core Facility, Baylor College of Medicine, Houston, TX, USA.

Ilya Levental (I)

Department of Integrative Biology and Pharmacology, McGovern Medical School, the University of Texas Health Sciences Center (UTHealth), Houston, TX, USA.
Graduate Program in Biochemistry and Cell Biology, MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.

Dharini van der Hoeven (D)

Department of Diagnostic and Biomedical Sciences, School of Dentistry, The University of Texas Health Science Center, Houston, TX, USA.

Yong Zhou (Y)

Department of Integrative Biology and Pharmacology, McGovern Medical School, the University of Texas Health Sciences Center (UTHealth), Houston, TX, USA.
Graduate Program in Biochemistry and Cell Biology, MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.

John F Hancock (JF)

Department of Integrative Biology and Pharmacology, McGovern Medical School, the University of Texas Health Sciences Center (UTHealth), Houston, TX, USA.
Graduate Program in Biochemistry and Cell Biology, MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.

Kartik Venkatachalam (K)

Department of Integrative Biology and Pharmacology, McGovern Medical School, the University of Texas Health Sciences Center (UTHealth), Houston, TX, USA Kartik.venkatachalam@uth.tmc.edu.
Graduate Program in Biochemistry and Cell Biology, MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH